Xifaxan in Denmark: Rifaximin Treatment Information and Pharmacy Access

About Xifaxan

Xifaxan is a brand name for rifaximin, an antibiotic that acts mainly within the gastrointestinal tract. Because only a small amount is normally absorbed into the bloodstream, its clinical action is concentrated in the gut. Treatment should follow an assessment by a qualified healthcare professional.

Rifaximin is used for selected digestive and liver-related conditions where changes in intestinal bacteria are clinically relevant. The approved indications, dose, and treatment duration can differ between countries and individual products. In Denmark, patients should rely on the product information supplied with the dispensed medicine.

This medicine is not a general remedy for every episode of diarrhoea or abdominal discomfort. Symptoms such as fever, blood in stool, severe dehydration, or persistent pain require timely medical evaluation. Antibiotic use is most appropriate when there is a clear medical reason.

Active Ingredient and Development

The active ingredient in Xifaxan is rifaximin, a semisynthetic derivative related to rifamycin antibiotics. It was developed to provide antibacterial activity in the intestinal lumen with limited systemic exposure. This characteristic distinguishes it from antibiotics that circulate widely throughout the body.

Rifaximin emerged from research into rifamycin compounds and their ability to inhibit bacterial RNA production. Its formulation was designed to remain largely in the digestive tract after oral administration. Researchers have subsequently studied it in several conditions involving the gut microbiome and bacterial metabolism.

Brand availability and authorised uses have evolved over time across different health systems. A medicine marketed under the Xifaxan name in one country may not have identical presentations or approved uses elsewhere. Danish patients should confirm the exact product and indication with a pharmacist or prescriber.

What Xifaxan May Be Used For

Depending on local authorisation, rifaximin may be used for certain bacterial intestinal infections, traveller’s diarrhoea caused by non-invasive bacteria, or prevention of recurrent hepatic encephalopathy. It has also been studied and authorised in some markets for selected patients with irritable bowel syndrome with diarrhoea. These uses are not interchangeable.

Hepatic encephalopathy is a complication of significant liver disease in which substances produced in the gut can affect brain function. In this setting, rifaximin may be used alongside other measures chosen by the treating clinician. Confusion, marked drowsiness, personality change, or altered consciousness need urgent medical attention.

For acute diarrhoea, the cause matters before an antibiotic is considered. Viral illness, invasive bacterial infection, inflammatory bowel disease, food intolerance, and medicine-related diarrhoea require different approaches. A healthcare professional can determine whether Xifaxan is suitable rather than delaying needed care.

How Rifaximin Works

Rifaximin blocks bacterial RNA polymerase, an enzyme bacteria need to make RNA and maintain essential cellular functions. This inhibits the growth or survival of susceptible bacteria in the intestine. Its action is antibacterial rather than a direct treatment for pain, dehydration, or inflammation.

Low absorption is a central feature of rifaximin, although absorption may increase in people with damaged intestinal lining or severe liver impairment. Limited bloodstream exposure can reduce some systemic effects, but it does not eliminate the possibility of adverse reactions or interactions. The medicine should therefore still be used with appropriate clinical oversight.

The intestinal microbiome is complex, and rifaximin does not affect every organism in the same way. Response can depend on the condition being treated, the dose used, and individual health factors. Completing or stopping a course should be discussed with the prescriber rather than decided from symptoms alone.

Available Forms and Strengths

Xifaxan is commonly supplied as oral film-coated tablets, although the strengths marketed vary by country. Rifaximin tablet strengths seen internationally include 200 mg and 550 mg. The box, leaflet, and pharmacy label identify the actual strength and instructions for the product dispensed.

Different strengths are used for different indications, so tablets should not be substituted or split without professional advice. A lower-strength short course for an intestinal infection is not equivalent to a maintenance regimen used for recurrent hepatic encephalopathy. Dose schedules must be tailored to the approved indication and patient circumstances.

Availability in Denmark may depend on national authorisation, supply arrangements, and whether a suitable alternative is prescribed. A pharmacist can help identify the authorised presentation and explain whether a prescribed medicine can be obtained. Do not use imported or unfamiliar packaging without verifying its source and contents.

How to Take Xifaxan

Take Xifaxan exactly as stated on the prescription label and in the patient information leaflet. Tablets are generally swallowed with water and may usually be taken with or without food, unless the prescriber gives different instructions. Taking doses at consistent times can help maintain the intended regimen.

If a dose is missed, follow the instructions provided with the medicine or ask a pharmacist for guidance. Do not take an extra dose simply to compensate unless a clinician specifically tells you to do so. Taking more than prescribed can increase risk without improving treatment.

Keep follow-up appointments when Xifaxan is prescribed for an ongoing condition such as liver-related encephalopathy prevention. The prescriber may monitor symptoms, other medicines, liver health, and the continued need for therapy. Contact the care team if symptoms worsen or do not improve as expected.

Expected Onset and Duration of Effect

The time to improvement with Xifaxan depends on the condition being treated and the underlying cause of symptoms. Some people with a susceptible intestinal bacterial condition may notice improvement during a short treatment course. Others, especially those using rifaximin to reduce recurrence of a chronic complication, may need continued therapy for preventive benefit.

Rifaximin’s antibacterial activity occurs while the medicine is present in the intestinal tract. Its clinical benefit can persist beyond an individual dose, but this should not be interpreted as a reason to alter the prescribed schedule. The duration of benefit varies substantially between patients.

Seek medical advice rather than extending treatment independently if diarrhoea, abdominal symptoms, or confusion continues. Persistent symptoms can signal an alternative diagnosis, treatment failure, dehydration, or a complication requiring a different intervention. Urgent symptoms should be assessed without delay.

How Long Xifaxan Remains in the Body

Most rifaximin remains in the gastrointestinal tract and is eliminated mainly through faeces. Only a limited fraction is usually absorbed into the bloodstream in people with normal intestinal function. This means blood-based elimination timelines are less informative than for many other antibiotics.

Any absorbed rifaximin is processed and cleared over time, but the exact duration can vary with liver function, intestinal disease, dose, and individual physiology. Severe liver impairment may lead to greater systemic exposure. A clinician can assess whether this affects the suitability of treatment.

Feeling better does not necessarily mean all treatment-related effects have ended, and side effects can require attention during or shortly after a course. Tell healthcare professionals about recent rifaximin use when discussing new gastrointestinal symptoms. This is particularly important if severe or prolonged diarrhoea develops.

Clinical Research and Evidence

Clinical research has evaluated rifaximin in carefully defined gastrointestinal and liver-related settings. Evidence supports use only for particular indications, doses, and patient groups that have been assessed in clinical studies and regulatory reviews. Results from one condition should not be assumed to apply to another.

Studies of rifaximin commonly assess symptom control, recurrence rates, safety, and the need for additional treatment. Research also examines how changes in intestinal bacteria may contribute to its effects. The evidence base continues to develop, particularly regarding microbiome-related conditions.

Clinical guidelines and product authorisations may differ between countries because they consider local approvals and healthcare practice. A prescriber can interpret the available evidence in relation to an individual’s diagnosis and medical history. Personal treatment decisions should not be based solely on general information pages.

Dependence and Addiction Potential

Xifaxan is not considered a medicine that causes addiction or drug-seeking dependence in the way that opioids, sedatives, or some stimulants can. It does not produce the typical intoxication or withdrawal pattern associated with those medicines. Nevertheless, it should be used only for the intended medical purpose.

Long-term use may be appropriate for some approved indications, but this is different from dependence. Continued treatment should be regularly reviewed to ensure that benefits remain meaningful and that the regimen is still appropriate. Do not stop a preventive regimen abruptly without discussing it with the treating team.

Antibiotic stewardship remains important even when systemic absorption is low. Unnecessary or inappropriate antibiotic exposure may contribute to resistance and can disrupt normal gut bacteria. Use only the prescribed dose for the prescribed indication.

Side Effects and Allergic Reactions

Possible side effects of rifaximin include nausea, abdominal discomfort, bloating, headache, dizziness, constipation, or diarrhoea. Some of these symptoms may also be related to the condition being treated. Report troublesome, persistent, or unexpected symptoms to a pharmacist or clinician.

Serious allergic reactions are uncommon but require urgent care. Warning signs can include hives, a widespread rash, swelling of the face or throat, wheezing, trouble breathing, or faintness. Stop taking the medicine and seek emergency help if these symptoms occur.

All antibiotics can be associated with significant changes in bowel habits, including diarrhoea related to Clostridioides difficile infection. Severe, persistent, watery, or bloody diarrhoea should be assessed promptly, including if it occurs after treatment has ended. Do not self-treat severe symptoms with anti-diarrhoeal products without medical guidance.

Who Should Not Take Xifaxan

People with a known allergy to rifaximin, rifamycin antibiotics, or any listed tablet ingredient should not take Xifaxan unless a specialist determines otherwise. A prior severe medicine reaction should always be discussed before treatment. The dispensing pharmacist should be told about all known allergies.

Rifaximin may not be suitable for diarrhoea accompanied by fever or blood in the stool, especially when invasive infection is possible. These features may need assessment and a different treatment approach. Medical review is also important for severe dehydration, repeated vomiting, or rapidly worsening illness.

People with significant liver disease, intestinal ulceration, inflammatory bowel disease, or a history of antibiotic-associated colitis need individual assessment. Pregnancy, breastfeeding, and plans for pregnancy should be discussed with a clinician because suitability depends on the clinical situation. Never share prescribed antibiotics with another person.

Age Limits and Special Populations

Age restrictions for Xifaxan depend on the indication, tablet strength, and the locally approved product information. Some uses may be limited to adults, while other uses may have specific paediatric criteria. A child should receive rifaximin only when a clinician has selected an appropriate product and dose.

Older adults may use rifaximin when clinically indicated, but they often take multiple medicines and may have additional health conditions. Medication review is particularly important where liver disease, kidney disease, frailty, or dehydration is present. The prescriber may consider these factors when deciding on treatment.

During pregnancy or breastfeeding, treatment decisions should balance the medical need against available safety information. Do not start, continue, or stop Xifaxan in these circumstances without professional advice. A pharmacist can explain what information is available for the exact presentation supplied.

Alcohol and Medicine Interactions

There is no well-established direct alcohol interaction that makes rifaximin universally incompatible with alcohol, but alcohol may worsen gastrointestinal symptoms and dehydration. For people with liver disease or hepatic encephalopathy, alcohol can be particularly harmful and should be avoided unless their specialist advises otherwise. Follow the recommendations of the clinician managing the underlying condition.

Tell the prescriber and pharmacist about prescription medicines, non-prescription products, herbal preparations, and supplements. Although rifaximin is minimally absorbed, interaction risk cannot be assumed to be absent for every person. Medicines affecting liver transport systems or intestinal function may warrant particular review.

Changes in mental alertness, unusual bruising, worsening liver symptoms, or severe digestive symptoms should be reported promptly. These signs may relate to the underlying illness, another medicine, or an adverse effect requiring assessment. Keep an up-to-date medicines list for every healthcare appointment.

Overdose and Urgent Concerns

If more Xifaxan than prescribed has been taken, contact a pharmacist, doctor, or poison information service for individual advice. Provide the tablet strength, estimated amount, time taken, age, body weight, and other medicines involved. Do not wait for symptoms before seeking guidance when a substantial excess may have been taken.

Emergency help is needed for breathing difficulty, facial swelling, collapse, seizure, severe confusion, or inability to stay awake. These symptoms may indicate a serious reaction or another urgent medical problem. In Denmark, use the appropriate emergency service for immediate danger.

Keep the medicine carton or blister pack available when asking for help. Packaging helps clinicians identify the active ingredient, strength, and batch details. Do not induce vomiting unless specifically instructed by a healthcare professional.

Storage and Safe Handling

Store Xifaxan in its original packaging at the conditions stated on the carton and leaflet. Protect the tablets from unnecessary heat, moisture, and direct sunlight. Avoid keeping medicines in a humid bathroom or a place accessible to children.

Check the expiry date before use and do not take tablets that are damaged, discoloured, or stored outside the recommended conditions. Expired or unused antibiotics should not be kept for a future illness. Return unwanted medicines through an appropriate pharmacy disposal route rather than placing them in household waste or wastewater.

Keep the prescription label with the pack so that the patient name and dosing instructions remain clear. This reduces the risk of accidental use by another household member. Safe storage is especially important where children, visitors, or vulnerable adults are present.

Alternatives to Xifaxan

Alternatives depend entirely on why rifaximin has been prescribed. For bacterial diarrhoea, supportive hydration, diagnostic testing, or another antimicrobial may be more appropriate depending on the suspected cause and resistance patterns. For liver-related encephalopathy, clinicians may consider therapies that reduce intestinal ammonia production alongside management of liver disease.

For diarrhoea-predominant irritable bowel syndrome, options can include dietary approaches, symptom-directed medicines, and therapies chosen after evaluation for other causes. These are not direct substitutes for rifaximin in every patient. A clinician should guide any switch to avoid missed diagnoses or unsuitable treatment.

Do not replace Xifaxan with another antibiotic from a previous prescription. Antibiotics differ in spectrum, absorption, safety profile, and approved uses. A pharmacist can discuss available prescribed alternatives if a particular presentation is unavailable.

Prescription Status in Denmark

Xifaxan and rifaximin products are generally medicines that require a valid prescription in regulated pharmacy supply. Whether a specific strength or brand is available in Denmark must be confirmed through an authorised prescriber and pharmacy. Requirements can change with national authorisation and supply status.

A legitimate pharmacy will ask for the information required under Danish medicines rules before dispensing a prescription medicine. It should not imply that clinical assessment or a valid prescription can be bypassed for an antibiotic. This protects patients from counterfeit, unsuitable, or incorrectly dosed products.

If you already have a valid prescription, ask the pharmacy whether it can be dispensed, transferred, or fulfilled through its approved service. If you do not have one, arrange a consultation with an appropriately licensed clinician. This is the safest route to treatment that matches the diagnosis.

Costs at Danish Pharmacies

The cost of rifaximin can vary according to strength, pack size, brand availability, reimbursement eligibility, and pharmacy service charges. Other pharmacy websites may show different listed costs, but those figures may not include delivery, consultation, or dispensing fees. Current costs should be checked directly with an authorised Danish pharmacy.

Patients should compare the same strength, quantity, and authorised product when considering options. A lower headline amount can be misleading if the pack contains fewer tablets or if additional charges apply later. Pharmacists can also explain whether a prescribed alternative has a different cost profile.

Do not select a supplier solely because it appears unusually inexpensive. Authentic medicines require regulated sourcing, professional dispensing, and secure handling. Verifying the pharmacy’s legal status is more important than pursuing an unverified offer.

Benefits of Regulated Digital Pharmacy Services

A regulated digital pharmacy service can make prescription management more convenient for people who cannot easily visit a branch. It may allow patients to submit prescription details, review dispensing information, and arrange delivery where this is permitted. Secure services should protect personal and health information.

Patients may buy Xifaxan through a properly authorised pharmacy service only after the required prescription checks have been completed. The pharmacy should provide a way to ask medicine-related questions before dispensing. Clear contact information and professional accountability are important signs of a trustworthy provider.

Digital ordering does not replace urgent medical assessment. New severe symptoms, signs of dehydration, allergic symptoms, or changes in consciousness need direct healthcare attention. A pharmacy service is most useful when it operates as part of safe, regulated care.

How to Arrange Supply and Track Delivery

Begin by confirming that you have a valid prescription for the exact rifaximin product and dose prescribed. Provide accurate patient, delivery, and contact details through the pharmacy’s secure process. Review the order information carefully before confirming it.

After a prescription is validated and the medicine is dispensed, the pharmacy may provide delivery updates or a tracking reference where available. Check that the delivery address is secure and that someone can receive the package if required. Contact the pharmacy promptly if tracking indicates a delay, damage, or delivery issue.

On receipt, inspect the package and confirm that the patient name, medicine name, strength, and directions match the prescription. Read the enclosed leaflet before starting treatment and keep it for reference. Contact the pharmacy immediately if anything appears incorrect or if you have questions about using Xifaxan.

Frequently Asked Questions

Can Xifaxan be used alongside a low-FODMAP diet for IBS with diarrhoea?

For some people with IBS with diarrhoea, dietary measures and rifaximin may be considered as separate parts of a clinician-led management plan. A low-FODMAP diet is usually intended as a time-limited, structured trial, ideally with support from a qualified dietitian. Do not make major dietary restrictions or change treatment solely on the basis of symptom fluctuations.

Can symptoms return after a course of Xifaxan?

Symptoms can recur, depending on the condition being treated and its underlying cause. If symptoms return, contact the prescriber rather than restarting leftover tablets or seeking repeated courses independently. The appropriate next step may include reassessment of the diagnosis, contributing factors, and whether further treatment is suitable.

Does Xifaxan affect hormonal contraception?

Rifaximin is minimally absorbed into the bloodstream, so a clinically important effect on hormonal contraception is not generally expected. However, vomiting or severe diarrhoea can reduce absorption of oral contraceptive pills. Check the contraceptive product information and ask a pharmacist or prescriber whether backup contraception is appropriate for your situation.

Can Xifaxan be taken with probiotics?

There is no universal requirement to take a probiotic with Xifaxan, and the benefit varies by person and condition. Some probiotic products may not be suitable for people with significant immune suppression or severe illness. Discuss the specific product with a pharmacist or clinician before combining it with prescribed treatment.

What should I do if I develop fever, blood in the stool, or worsening diarrhoea while using Xifaxan?

Fever, bloody stools, marked abdominal pain, dehydration, or worsening diarrhoea need prompt medical assessment, as they may indicate an illness that requires a different approach. Do not rely on Xifaxan alone to manage these warning signs. Seek urgent care if symptoms are severe or you are unable to keep fluids down.

Can Xifaxan be used for diarrhoea after international travel?

Rifaximin may be considered for selected cases of travellers’ diarrhoea, but it is not appropriate for every type of infectious diarrhoea. In particular, fever or blood in the stool warrants medical assessment rather than self-treatment. Before travelling from Denmark, ask a healthcare professional about prevention, hydration, and which medicines are appropriate for your destination.

Does Xifaxan interact with warfarin or other blood thinners?

Changes in blood-clotting test results have been reported in some people taking rifaximin with warfarin. Anyone using warfarin should tell the prescriber and anticoagulation clinic about Xifaxan so that appropriate monitoring can be arranged. Do not adjust the dose of a blood thinner without clinical guidance.

Can I switch between Xifaxan and a rifaximin generic product?

Products containing rifaximin may differ in authorised strengths, indications, packaging, and availability. A pharmacist can confirm whether a substitution is appropriate for the prescribed regimen and permitted under Danish dispensing rules. Use the product supplied for your prescription and avoid mixing tablets from different packs unless a healthcare professional has advised it.

Pharmacist Review

The current Xifaxan product-page content has been professionally reviewed for pharmaceutical clarity, balanced safety information, and relevance to patients in Denmark.

Review detail	Information
Reviewed by	Mette Nørgaard Jensen, Master of Pharmacy (cand.pharm.)
Professional identifier	Authorisation ID: 784521
Professional authority	Danish Patient Safety Authority
Review date	24 March 2025

Information regarding Xifaxan, including its uses, administration, precautions, interactions, and possible adverse effects, has been checked against recognised pharmaceutical standards. Treatment decisions should always consider the individual patient, diagnosis, prescribed dose, and other medicines used.

Medical disclaimer: This material is provided for informational purposes only and does not replace consultation with a doctor.

Pharmacy Location and Opening Hours

Find Xifaxan at our pharmacy in Copenhagen.

Address: Vesterbrogade 6, 1620 Copenhagen, Capital Region of Denmark, DK

Days	Opening hours
Monday–Friday	07:00–24:00
Saturday	08:00–24:00
Sunday	10:00–24:00